Skip to main content
logo
Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
23.56
-0.09 (-0.38%)
At close: Apr 28, 2026, 4:00 PM EDT
23.42
-0.14 (-0.59%)
After-hours: Apr 28, 2026, 7:38 PM EDT

Legend Biotech Revenue

In the year 2025, Legend Biotech had annual revenue of $1.03B with 64.02% growth. Legend Biotech had revenue of $306.30M in the quarter ending December 31, 2025, with 64.24% growth.

Revenue (ttm)
$1.03B
Revenue Growth
+64.02%
P/S Ratio
4.23
Revenue / Employee
$347,015
Employees
2,965
Market Cap
4.36B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 20251.03B401.60M64.02%
Dec 31, 2024627.30M342.20M120.03%
Dec 31, 2023285.10M168.10M143.66%
Dec 31, 2022117.01M48.18M70.00%
Dec 31, 202168.83M-6.17M-8.23%
Dec 31, 202075.00M15.02M25.04%
Dec 31, 201959.98M10.85M22.08%
Dec 31, 201849.13M25.54M108.24%
Dec 31, 201723.59M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
ACADIA Pharmaceuticals1.07B
Corcept Therapeutics761.41M
Amicus Therapeutics634.21M
Travere Therapeutics490.73M
Ligand Pharmaceuticals268.09M
Tango Therapeutics62.38M
Crinetics Pharmaceuticals7.70M
CRISPR Therapeutics AG3.51M
Revenue Rankings

LEGN News

More News